From Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug:

white-human-brain-picture-id627014070

white-human-brain-picture-id627014070—

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!